HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgical resection and liposomal amphotericin B to treat cavitary pulmonary zygomycosis in a patient with diabetes.

Abstract
We describe a 24-year-old man with type 1 diabetes mellitus and a cavitary lesion in the right upper lobe, caused by a zygomycete. Surgical resection plus liposomal amphotericin B therapy was successful. We discuss predisposing condition, clinical findings, diagnosis, and treatment of pulmonary zygomycosis.
AuthorsZhu Hua-Ping, Liang Jian, Huang Jing-Bin, Gao Jie, Mo Guo-Xin, Jia Yan-Hong, Xie Li-Xin
JournalRespiratory care (Respir Care) Vol. 56 Issue 11 Pg. 1837-9 (Nov 2011) ISSN: 0020-1324 [Print] United States
PMID21605482 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antifungal Agents
  • Liposomes
  • Amphotericin B
Topics
  • Amphotericin B (administration & dosage)
  • Antifungal Agents (administration & dosage)
  • Comorbidity
  • Diabetes Mellitus (epidemiology)
  • Humans
  • Immunocompromised Host
  • Liposomes
  • Lung Diseases, Fungal (drug therapy, epidemiology, surgery, therapy)
  • Male
  • Young Adult
  • Zygomycosis (drug therapy, epidemiology, surgery, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: